Medicina
Department
University of Glasgow
Glasgow, Reino UnidoPublications in collaboration with researchers from University of Glasgow (79)
2023
-
Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results from a Randomized, Open-Label, Phase III Trial
Journal of Clinical Oncology, Vol. 41, Núm. 11, pp. 2007-2019
-
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 19, Núm. 6, pp. 464-481
-
Comparison of the Accuracy of the 7-Item HADS Depression Subscale and 14-Item Total HADS for Screening for Major Depression: A Systematic Review and Individual Participant Data Meta-Analysis
Psychological Assessment, Vol. 35, Núm. 2, pp. 94-114
-
Evolving Management Paradigm for Stable Ischemic Heart Disease Patients: JACC Review Topic of the Week
Journal of the American College of Cardiology, Vol. 81, Núm. 5, pp. 505-514
-
Impact of Post-PCI FFR Stratified by Coronary Artery
JACC: Cardiovascular Interventions, Vol. 16, Núm. 19, pp. 2396-2408
-
Machine learning for diagnosis of myocardial infarction using cardiac troponin concentrations
Nature Medicine, Vol. 29, Núm. 5, pp. 1201-1210
-
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
European Urology
-
Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022
European Journal of Cancer
-
Rationale and design of the pullback pressure gradient (PPG) global registry
American Heart Journal, Vol. 265, pp. 170-179
-
Results from a Phase 1b/2 Study of Ibrutinib Combination Therapy in Advanced Urothelial Carcinoma
Cancers, Vol. 15, Núm. 11
2022
-
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function
Kidney International, Vol. 101, Núm. 1, pp. 174-184
-
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up
European Heart Journal, Vol. 43, Núm. 11, pp. 1059-1103
-
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial
The Lancet Diabetes and Endocrinology, Vol. 10, Núm. 1, pp. 35-45
-
Erratum: Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (European journal of human genetics : EJHG (2022) 30 3 (349-362))
European journal of human genetics : EJHG
-
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
European Heart Journal, Vol. 43, Núm. 11, pp. 1033-1058
-
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
Cardiovascular research, Vol. 118, Núm. 6, pp. 1385-1412
-
Polygenic risk modeling for prediction of epithelial ovarian cancer risk
European journal of human genetics : EJHG, Vol. 30, Núm. 3, pp. 349-362
2021
-
Effects of a Novel Nitroxyl Donor in Acute Heart Failure: The STAND-UP AHF Study
JACC: Heart Failure, Vol. 9, Núm. 2, pp. 146-157
-
Effects of dapagliflozin on mortality in patients with chronic kidney disease: A pre-specified analysis from the DAPA-CKD randomized controlled trial
European Heart Journal, Vol. 42, Núm. 13, pp. 1216-1227
-
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR
European Heart Journal, Vol. 42, Núm. 45, pp. 4624-4634